Denali recruits Genentech vet Carole Ho as CMO

Carole Ho

The Genentech vets behind South San Francisco-based Denali Therapeutics have recruited one of their former colleagues to join them as CMO and head of development. Carole Ho, former VP of early clinical development at Genentech, was tapped for the job. Denali turned heads a few months ago when it announced a whopping $217 million round to back their work on neurodegenerative diseases. Release